These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography. Shin DS, Shon OJ, Byun SJ, Choi JH, Chun KA, Cho IH. Skeletal Radiol; 2008 May; 37(5):415-21. PubMed ID: 18309481 [Abstract] [Full Text] [Related]
3. Prevalence and patterns of bone metastases detected with positron emission tomography using F-18 FDG. Nakamoto Y, Osman M, Wahl RL. Clin Nucl Med; 2003 Apr; 28(4):302-7. PubMed ID: 12642709 [Abstract] [Full Text] [Related]
4. Utility of FDG-PET in differential diagnosis of benign and malignant fractures in acute to subacute phase. Kato K, Aoki J, Endo K. Ann Nucl Med; 2003 Feb; 17(1):41-6. PubMed ID: 12691129 [Abstract] [Full Text] [Related]
13. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Shreve PD, Anzai Y, Wahl RL. Radiographics; 1999 Feb; 19(1):61-77; quiz 150-1. PubMed ID: 9925392 [Abstract] [Full Text] [Related]
14. FDG-PET in a case of multiple bone metastases of gastric cancer. Nakai T, Okuyama C, Kubota T, Ushijima Y, Nishimura T. Ann Nucl Med; 2005 Feb; 19(1):51-4. PubMed ID: 15770974 [Abstract] [Full Text] [Related]
15. Avoidance of misinterpretation of an FDG positive sacral insufficiency fracture using PET/CT scans in a patient with endometrial cancer: a case report. Halaç M, Mut SS, Sönmezoglu K, Ylmaz MH, Ozer H, Uslu I. Clin Nucl Med; 2007 Oct; 32(10):779-81. PubMed ID: 17885357 [Abstract] [Full Text] [Related]